Patents Assigned to OssiFi, Inc.
  • Patent number: 8877196
    Abstract: The present invention provides a method of promoting local bone growth by administering a therapeutic amount of a Sost antagonist to a mammalian patient in need thereof. Preferably, the Sost antagonist is an antibody or FAB fragment selectively recognizing any one of SEQ ID NOS: 1-23. The Sost antagonist may be coadministered together or sequentially with a matrix conducive to anchoring new bone growth. Orthopedic and Periodontal devices comprising an implantable portion adapted to be permanently implanted within a mammalian body and bearing an external coating of a Sost antagonist are also disclosed, as it a method of increasing bone density by administering to a mammalian patient a therapeutic amount of a Sost antagonist together with an antiresorptive drug.
    Type: Grant
    Filed: March 12, 2013
    Date of Patent: November 4, 2014
    Assignee: OssiFi Inc.
    Inventor: Debra L. Ellies
  • Publication number: 20140288068
    Abstract: In one aspect, the invention provides compounds of Formula I, and salts, hydrates and isomers thereof. In another aspect, the invention provides a method of promoting bone formation in a subject in need thereof by administering to the subject a therapeutically effective amount of a compound of Formula I, Formula II, or Formula III. The present invention also provides orthopedic and periodontal devices, as well as methods for the treatment of renal disease and cancer, using a compound of Formula I, Formula II, or Formula III.
    Type: Application
    Filed: March 14, 2014
    Publication date: September 25, 2014
    Applicant: OssiFi Inc.
    Inventors: Debra Ellies, Jean-Philippe Rey, F. Scott Kimball
  • Publication number: 20130195856
    Abstract: The present invention provides a method of promoting local bone growth by administering a therapeutic amount of a Sost antagonist to a mammalian patient in need thereof. Preferably, the Sost antagonist is an antibody or FAB fragment selectively recognizing any one of SEQ ID NOS: 1-23. The Sost antagonist may be coadministered together or sequentially with a matrix conducive to anchoring new bone growth. Orthopedic and Periodontal devices comprising an implantable portion adapted to be permanently implanted within a mammalian body and bearing an external coating of a Sost antagonist are also disclosed, as it a method of increasing bone density by administering to a mammalian patient a therapeutic amount of a Sost antagonist together with an antiresorptive drug.
    Type: Application
    Filed: March 12, 2013
    Publication date: August 1, 2013
    Applicant: OSSIFI INC.
    Inventor: OssiFi Inc.
  • Patent number: 8460642
    Abstract: The present invention provides a method of promoting bone growth in a subject in need thereof, by administering to the subject a therapeutically effective amount of a compound of Formula I. The present invention also provides methods for the treatment of renal disease and cancer.
    Type: Grant
    Filed: April 25, 2012
    Date of Patent: June 11, 2013
    Assignee: OssiFi, Inc.
    Inventors: Debra Ellies, William Rosenberg